ORIX Corporation's FY2026 year-to-date net income and repurchases surpassed expectations, which supports my "Buy" rating. The company's ROE improved to 12% in 9MFY26, justifying a higher 1.8x P/B ...
I upgrade my rating for CBA to a Hold, due to its superior ROE and dividend payout ratio relative to peers, but a Gordon Growth Model valuation analysis indicates that CBA is fairly valued and ...